Inavolisib Combo Receives EU Approval in PIK3CA+ ER+/HER2– Breast Cancer
An important advancement has been made in the field of oncology with the EU approving a specific drug combo Inavolisib, for a type of breast cancer.
Refining Management of Immune-Checkpoint Inhibitor Toxicities in Melanoma
Advancements have also been made in the management of immune-checkpoint inhibitor toxicities in Melanoma.
FDA Grants Fast Track Designation to SRN-101 for Recurrent High-Grade Glioma
Another breakthrough is the FDA’s fast track designation to SRN-101 for the treatment of high-grade Glioma.
Novel Small Molecule Shows Early Activity in Pretreated Multiple Myeloma
Significantly, a new small molecule showcasing promising early activity in treating multiple myeloma, indicating a potential new direction in treatment approaches for this form of cancer.
Comparing Quality of Life Outcomes with Protons vs Photons in OPSCC
On quality of life in cancer treatment, a comparison of outcomes with different treatments for a specific cancer has been discussed.
3 Things You Should Know About PSMA-Directed Imaging and Radioligand Therapy in Prostate Cancer
To conclude, essential information is offered about PSMA-Directed Imaging and radioligand therapy, a specific method used in treating prostate cancer.
